非经典PRC1功能不足与JAK2V617F协同促进骨髓纤维化发生
该研究在JAK2V617F小鼠中敲除PRC1.1组分Pcgf1,发现其强烈促进致死性骨髓纤维化并伴红系分化阻滞。转录组和ChIP-seq显示PRC1.1靶基因去抑制,Hoxa簇基因为直接靶点;Hoxa9过表达可增强JAK2V617F介导的骨髓纤维化。结果提示PRC1.1在骨髓纤维化中发挥抑癌功能,且其功能不足与PRC2不足对发病的影响不同。
要点
- Pcgf1缺失在JAK2V617F小鼠中促进致死性骨髓纤维化并阻滞红系分化。
- PRC1.1靶基因去抑制,Hoxa簇基因为直接靶点,Hoxa9过表达增强骨髓纤维化。
- PRC1.1不足与PRC2不足对骨髓纤维化发病机制的影响不同。
核心结论
- PRC1.1在骨髓纤维化中发挥抑癌功能,其功能不足与JAK2V617F协同促进骨髓纤维化发生。
研究设计与样本
- 在JAK2V617F小鼠模型中删除Pcgf1基因,结合转录组和染色质免疫沉淀测序分析。
主要发现
- Pcgf1缺失在JAK2V617F小鼠中强烈促进致死性骨髓纤维化,并伴随红系分化阻滞。
- Pcgf1缺陷的JAK2V617F造血祖细胞中PRC1.1靶基因去抑制,Hoxa簇基因为直接靶点。
- 在JAK2V617F造血干细胞和祖细胞中删除Pcgf1或过表达Hoxa9可恢复减弱的增殖。
- Hoxa9过表达增强JAK2V617F介导的骨髓纤维化。
- PRC2不足的JAK2V617F造血干细胞和祖细胞中鉴定的PRC2靶基因表达在Pcgf1缺失的JAK2V617F造血干细胞和祖细胞中未大幅改变。
临床怎么用
- 提示PRC1.1功能状态可能影响JAK2V617F阳性骨髓纤维化的疾病进展,但尚需临床验证。
局限性
- 研究基于小鼠模型,未在人类样本中验证PRC1.1功能不足的临床相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Insufficiency of polycomb repressive complex 2 (PRC2), which trimethylates histone H3 at lysine 27, is frequently found in primary myelofibrosis and promotes the development of JAK2V617F-induced myelofibrosis in mice by enhancing the production of dysplastic megakaryocytes. Polycomb group ring finger protein 1 (Pcgf1) is a component of PRC1.1, a non-canonical PRC1 that monoubiquitylates H2A at lysine 119 (H2AK119ub1). We herein investigated the impact of PRC1.1 insufficiency on myelofibrosis. The deletion of Pcgf1 in JAK2V617F mice strongly promoted the development of lethal myelofibrosis accompanied by a block in erythroid differentiation. Transcriptome and chromatin immunoprecipitation sequence analyses showed the de-repression of PRC1.1 target genes in Pcgf1-deficient JAK2V617F hematopoietic progenitors and revealed Hoxa cluster genes as direct targets. The deletion of Pcgf1 in JAK2V617F hematopoietic stem and progenitor cells (HSPCs), as well as the overexpression of Hoxa9, restored the attenuated proliferation of JAK2V617F progenitors. The overexpression of Hoxa9 also enhanced JAK2V617F-mediated myelofibrosis. The expression of PRC2 target genes identified in PRC2-insufficient JAK2V617F HSPCs was not largely altered in Pcgf1-deleted JAK2V617F HSPCs. The present results revealed a tumor suppressor function for PRC1.1 in myelofibrosis and suggest that PRC1.1 insufficiency has a different impact from that of PRC2 insufficiency on the pathogenesis of myelofibrosis.
引用
- Shinoda D, Nakajima-Takagi Y, Oshima M, et al. Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis. Leukemia. 2021. PMID: 34497325. doi:10.1038/s41375-021-01402-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。